Charles River Laboratories International (CRL) Profit After Tax (2009 - 2025)
Charles River Laboratories International (CRL) posted quarterly Profit After Tax of -$274.4 million for Q4 2025, down 29.79% year-over-year from -$390.8 million in Q4 2024, and down 604.17% quarter-over-quarter from $54.4 million in Q3 2025.
Charles River Laboratories International (CRL) Profit After Tax (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Profit After Tax history runs 17 years deep, the most recent figure standing at -$274.4 million for Q4 2025.
- In Q4 2025, Profit After Tax fell 29.79% year-over-year to -$274.4 million; the TTM figure through Dec 2025 stood at -$141.4 million (down 627.31% YoY), while the FY2025 annual figure was -$142.2 million, down 662.11% from the prior year.
- Profit After Tax for Q4 2025 stood at -$274.4 million, down from $54.4 million in the prior quarter.
- The five-year high for Profit After Tax was $189.1 million in Q4 2022, with the low at -$274.4 million in Q4 2025.
- The 5-year median for Profit After Tax is $91.5 million (2021), against an average of $61.9 million.
- The sharpest annual moves came in 2022 and 2024: Profit After Tax surged 51.18% in 2022, then tumbled 213.0% in 2024.
- Charles River Laboratories International's Profit After Tax stood at $132.0 million in 2021, then surged by 43.29% to $189.1 million in 2022, then declined by 1.07% to $187.1 million in 2023, then sank by 213.0% to -$211.4 million in 2024, then declined by 29.79% to -$274.4 million in 2025.
- Business Quant data shows CRL's Profit After Tax at -$274.4 million in Q4 2025, $54.4 million in Q3 2025, and $52.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 1.74 Bn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 258.00 Mn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | -85.09 Mn |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | 256.84 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 334.00 Mn |
| 10 | Charles River Laboratories International | 12.74 Bn | 12.53 Bn | 1.81 Bn | -274.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -274.38 Mn |
| Sep 27, 2025 | 54.42 Mn |
| Jun 28, 2025 | 52.69 Mn |
| Mar 29, 2025 | 25.88 Mn |
| Dec 28, 2024 | -211.41 Mn |
| Sep 28, 2024 | 69.66 Mn |
| Jun 29, 2024 | 94.08 Mn |
| Mar 30, 2024 | 74.48 Mn |
| Dec 30, 2023 | 187.08 Mn |
| Sep 30, 2023 | 87.39 Mn |
| Jul 1, 2023 | 99.44 Mn |
| Apr 1, 2023 | 103.13 Mn |
| Dec 31, 2022 | 189.11 Mn |
| Sep 24, 2022 | 97.61 Mn |
| Jun 25, 2022 | 109.32 Mn |
| Mar 26, 2022 | 93.02 Mn |
| Dec 25, 2021 | 131.97 Mn |
| Sep 25, 2021 | 103.43 Mn |
| Jun 26, 2021 | 89.92 Mn |
| Mar 27, 2021 | 61.53 Mn |